Cephalosporium is a Cutaneous; Intradermal; Subcutaneous Injection in the Non-standardized Allergenic category. It is labeled and distributed by Allermed Laboratories, Inc.. The primary component is Cephalosporium Roseum.
| Product ID | 49643-106_4f1be4f6-9f9e-5c19-e054-00144ff8d46c |
| NDC | 49643-106 |
| Product Type | Non-standardized Allergenic |
| Proprietary Name | Cephalosporium |
| Generic Name | Cephalosporium Roseum |
| Dosage Form | Injection |
| Route of Administration | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-12 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102211 |
| Labeler Name | Allermed Laboratories, Inc. |
| Substance Name | CEPHALOSPORIUM ROSEUM |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1974-03-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102211 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-12 |
| Marketing Category | BLA |
| Application Number | BLA102211 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-12 |
| Marketing Category | BLA |
| Application Number | BLA102211 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-12 |
| Marketing Category | BLA |
| Application Number | BLA102211 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1974-03-12 |
| Ingredient | Strength |
|---|---|
| CEPHALOSPORIUM ROSEUM | .1 g/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49288-0087 | Cephalosporium | Cephalosporium |
| 49288-0088 | Cephalosporium | Cephalosporium |
| 49288-0089 | Cephalosporium | Cephalosporium |
| 49643-106 | Cephalosporium | Cephalosporium roseum |